Literature DB >> 12162418

A 5-year survivor after resection of peritoneal metastases from pedunculated-type hepatocellular carcinoma.

Kiyotaka Kurachi1, Shohachi Suzuki, Yoshihiro Yokoi, Takuya Okumura, Keisuke Inaba, Tatsuya Igarashi, Yasuo Takehara, Hiroyuki Konno, Satoshi Baba, Satoshi Nakamura.   

Abstract

We report herein a 5-year survivor after the resection of peritoneal metastases from pedunculated hepatocellular carcinoma (HCC). A 42-year-old man underwent lateral segmentectomy of the liver, with a diagnosis of pedunculated HCC, on October 10, 1994. The lesion was associated with intratumoral hemorrhage and was covered by the greater omentum, but there were no peritoneal metastases. The patient was readmitted to our hospital 4 months later with right upper quadrant pain. His serum alpha-fetoprotein level was 3ng/dl. Hepatitis B virus surface antigen (HBsAg) and hepatitis C virus antibody (HCV-Ab) were both negative. Abdominal computed tomography (CT) revealed two nodular lesions in the right upper abdominal cavity. He was diagnosed with peritoneal metastases from HCC. Because there were no other distant metastases, laparotomy was performed to resect these tumors. We found two other tumors, located in the mesentery of the appendix and ileum. All four tumors were resected by partial transverse colectomy and appendectomy. The histopathology of the tumors showed poorly differentiated HCC (Edmondson-Steiner's grade III). The patient has been doing well without recurrent disease for more than 5 years after the second operation. The prognosis of patients with pedunculated HCC is poor. Furthermore, resection for peritoneal metastases from HCC is rare because of the presence of multiple seeding in the abdominal cavity and distant organ metastases. To our knowledge, our patient is the longest survivor after resection of peritoneal metastases from pedunculated HCC.

Entities:  

Mesh:

Year:  2002        PMID: 12162418     DOI: 10.1007/s005350200089

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  6 in total

1.  Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma.

Authors:  Kiminori Uka; Hiroshi Aikata; Shintaro Takaki; Hiroo Shirakawa; Soo-Cheol Jeong; Keitaro Yamashina; Akira Hiramatsu; Hideaki Kodama; Shoichi Takahashi; Kazuaki Chayama
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

Review 2.  Favorable control of hepatocellular carcinoma with peritoneal dissemination by surgical resection using indocyanine green fluorescence imaging: a case report and review of the literature.

Authors:  Yuma Tani; Hiroki Sato; Ryuichi Yoshida; Kazuya Yasui; Yuzo Umeda; Kazuhiro Yoshida; Tomokazu Fuji; Kenjiro Kumano; Kosei Takagi; Masaaki Kagoura; Takahito Yagi; Toshiyoshi Fujiwara
Journal:  J Med Case Rep       Date:  2022-06-06

Review 3.  Hepatocellular Carcinoma with Gastrointestinal Involvement: A Systematic Review.

Authors:  Cristiana Marinela Urhut; Larisa Daniela Sandulescu; Liliana Streba; Vlad Florin Iovanescu; Sarmis Marian Sandulescu; Suzana Danoiu
Journal:  Diagnostics (Basel)       Date:  2022-05-19

4.  Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution.

Authors:  Alfred Wei Chieh Kow; Choon Hyuck David Kwon; Sanghyun Song; Milljae Shin; Jong Man Kim; Jae-Won Joh
Journal:  Ann Surg Oncol       Date:  2012-03-09       Impact factor: 5.344

5.  Successful surgical resection for peritoneal implantation of hepatocellular carcinoma at the paracardial portion.

Authors:  Yuichi Sanada; Shinji Osada; Yasuharu Tokuyama; Yoshihiro Tanaka; Takao Takahashi; Kazuya Yamaguchi; Kazuhiro Yoshida
Journal:  J Oncol       Date:  2009-12-16       Impact factor: 4.375

6.  Giant pedunculated hepatocellular carcinoma masquerading as a pelvic mass: a case report.

Authors:  Hae Il Jung
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.